UNITED STATES |
FORM 8-K |
CURRENT REPORT |
July 26, 2005 |
CARACO PHARMACEUTICAL LABORATORIES, LTD. |
(Exact name of registrant as specified in its charter) |
Michigan | 0-24676 | 38-2505723 | ||
(State or other jurisdiction | (Commission file number) | (I.R.S. employer | ||
of incorporation) | identification no.) | |||
1150 Elijah McCoy Drive, Detroit, Michigan 48202 | ||||
(Address of principal executive offices) | ||||
(313) 871-8400 | ||||
(Registrants telephone number, including area code) | ||||
Not Applicable | ||||
(Former name or former address, if changed since last report) | ||||
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: | ||||
o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 140.14a-12) |
o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
|
Item 2.02. Results of Operations and Financial Condition |
On July 26, 2005, registrant announced its results of operations for the first quarter of its new fiscal year (the quarter ended June 30, 2005), as set forth in the press release included as Exhibit 99.1 hereto, which is incorporated herein by reference. |
Item 9.01. Financial Statements and Exhibits |
c) Exhibits |
Exhibit No. Description |
99.1 Press Release of Caraco Pharmaceutical Laboratories, Ltd., dated July 26, 2005 announcing its results of operations for its first quarter of fiscal 2006. |
SIGNATURES |
Pursuant to the requirements of the Securities Exchange Act of 1934, registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. |
CARACO PHARMACEUTICAL LABORATORIES, LTD. |
Date: July 26, 2005 | By: | /s/ Daniel H. Movens |
Daniel H. Movens | ||
Chief Executive Officer |
|
Exhibit Index |
99.1 | Press Release of Caraco Pharmaceutical Laboratories, Ltd., dated July 26, 2005 announcing its
results of operations for its first quarter of fiscal 2006. |
2 |